IUPHAR review: From gut to brain: The role of gut dysbiosis, bacterial amyloids, and metabolic disease in Alzheimer’s disease
Gut microbial dysbiosis, or altered gut microbial communities, in Alzheimer’s Disease suggests a pathogenic role for gut inflammation and microbial products in shaping a neuroinflammatory environment. Similarly, metabolic diseases, such as obesity and diabetes, are also associated with an increased...
Saved in:
| Main Authors: | Saadet Inan, R. Paul Wilson, Çagla Tükel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825001185 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut dysbiosis as a potential driver of Parkinson’s and Alzheimer’s disease pathogenesis
by: Jacob M. Pfaffinger, et al.
Published: (2025-08-01) -
Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01) -
Gut Microbiota and Alzheimer Disease
by: Lester Raymundo Dominguez Huarcaya
Published: (2025-01-01) -
Bidirectional modulation of Alzheimer’s disease via gut microbiota: rescue by fecal transplantation from healthy donors and aggravation by colitis-associated dysbiosis
by: Chenglong Zhou, et al.
Published: (2025-05-01) -
Amyloid immunotherapy for Alzheimer's disease: the case for cautious adoption
by: Jonathan M. Schott, et al.
Published: (2025-05-01)